In a recent Medical Research Council (MRC) grant submission for Brain BioLink OX.DH was selected as the expert industry partner with the University of Oxford, providing digital consenting technology. It addresses the challenges set out by the MRC/UKRI to deliver a novel, flexible model for a national translational neuroscience bioresource, integrating consent, PPI, samples, data, and quality assurance in partnership with industry.
In addition, OXDH is working with the University of Oxford to provide digital consent as part of the Brain Matrix Research Study Tessa Jowell BRAIN MATRIX and Genomics England to support the provision of a national platform for trialling precision medicine in the UK for those with brain tumours.